The vial is working and the price is right, but something about it still does not sit right. Knowing how to tell whether the GLP-1 in your refrigerator is compounded or FDA-approved takes about five minutes. This page walks through the checks in order. It matters because compounded semaglutide and tirzepatide have not been reviewed by the FDA for safety, quality or effectiveness. The agency has warned about dosing errors and adverse events with these products, including hospitalizations tied to patients measuring doses themselves from salt-based ingredients that the agency says should not be used to compound semaglutide at all.
At GoodLife Health the answer is settled before the first prescription is written: we prescribe branded, FDA-approved medication only, Wegovy, Zepbound, Ozempic, Mounjaro, Wegovy Tablets and Foundayo. Never compounded, under any circumstance. Here is how to tell what you have and what the difference costs you.
- Compounded GLP-1s do not undergo FDA premarket review for safety, quality or effectiveness.
- The FDA has documented dosing errors and serious adverse events tied to compounded injectable semaglutide.
- Five checks settle it: the label, the pharmacy, the price structure, the vial format and the website itself.
- GoodLife Health prescribes branded, FDA-approved GLP-1s only, with medication billed separately by the pharmacy at pharmacy cost.
Check one: read the label
A compounded vial names the active ingredient rather than the brand. You will see the word compounded on the label or the word semaglutide or tirzepatide written as the drug name, often with a volume concentration such as 2.5 mg/mL. A brand-name product carries the trade name: Wegovy, Zepbound, Ozempic or Mounjaro, with the manufacturer's name, Novo Nordisk or Eli Lilly, on the packaging.
The vial format is another tell. Wegovy and Zepbound in the United States now ship as single-dose autoinjectors or single-dose vials and Ozempic and Mounjaro as multi-dose prefilled pens. Compounded products overwhelmingly ship as multi-dose vials with syringes, because that format is cheaper to compound. If your plan arrived with vials and syringes rather than a pen, that is the compounded signature and the dosing risk the FDA describes, patients measuring their own doses with the wrong syringe, lives exactly there.
Check two: ask who the pharmacy is
Brand-name GLP-1s ship from licensed retail or specialty pharmacies with the manufacturer's cold chain behind them. Compounded products ship from compounding pharmacies, which is legal in specific circumstances but subjects the product to a different and far lighter oversight regime. If your platform cannot name the pharmacy or names one you have never heard of, that is an answer. Ask who fills it and who stands behind the cold chain.
Check three: read the price structure
The strongest tell is not on the label at all. Branded GLP-1s have list prices and pharmacy prices and no platform can honestly sell Wegovy at a steep discount unless the price is a loss-leader inside a membership or the product is not Wegovy. When a subscription charges one number for the medication plus dose changes, dose escalations that raise the price later or a tiered structure where stronger doses cost more, you are looking at the compounded economics. Brand-name products are priced by the manufacturer, not by your dose.
This is also the tell for the reverse case. If the platform quotes one flat fee that includes the medicine, something in that sentence is doing more work than it can honestly do. The fee and the medication are two different charges in any honest structure, because the doctor earns the first and the pharmacy earns the second.
Check four: count the dose levels
Compounded programs commonly advertise dose ranges that run far past the approved ceiling, sometimes advertising 12.5 mg or 15 mg weekly tirzepatide, doses that exist in no FDA-approved product. Approved Zepbound tops out at 15 mg in theory but is marketed in standard step-ups and approved Wegovy tops out at 2.4 mg weekly. A dose menu is a red flag. A titration schedule that follows the label is the branded signature.
Check five: ask the seller the direct question
Ask the platform one question in writing: is the medication you send me FDA-approved brand-name product and who is the pharmacy? The honest platforms answer both plainly. The others change the subject to testing, nutrition coaches or membership perks. That subject change is your answer.
Why GoodLife Health will not prescribe compounded
The position is structural rather than fashionable. The FDA has documented dosing errors, adverse events and salt-form ingredients in compounded semaglutide and tirzepatide products and our physicians will not put their names on that supply chain. When a branded GLP-1 is clinically indicated, we prescribe it and the pharmacy bills you at pharmacy cost with zero markup from us. When branded is clinically inappropriate, we do not quietly swap in a compounded copy to keep the subscription alive.
The flat $299 monthly fee covers the clinical relationship and the quarterly Biomarker Audit, four per year. The fee never changes with your dose, which removes the industry's favorite conflict: no one here profits when your dose goes up and no one here needs you on a higher strength to make the economics work. We make money when you get healthier, not when your dose gets stronger.
The $598 first charge covers the first two months and the first audit. It is held at sign-up and charged only once a clinician accepts you into care. If the clinician cannot accept you, the hold is released and you are never charged. Once accepted, the first two months are charged and non-refundable.
Who this is for and who it is not for
This is for the reader holding a vial of uncertain origin or comparing platforms and trying to understand why one quotes $199 and another quotes $499 for what sounds like the same molecule. It suits the person who wants branded product, a known pharmacy and a clinician who can explain the dose.
It is not for someone who wants the cheapest possible vial and nothing else. And it is not for anyone outside the United States, because our clinicians are licensed in the fifty states.
FAQ
Is my GLP-1 compounded or brand name?
Check the label first. Compounded vials name the ingredient, often with a concentration and usually arrive as multi-dose vials with syringes. Brand-name Wegovy, Zepbound, Ozempic and Mounjaro carry the trade name and manufacturer and ship as autoinjectors or prefilled pens. Asking the platform which pharmacy fills it settles the rest.
Are compounded GLP-1s legal?
Compounding itself is legal in specific circumstances and it became widespread during the recent shortages. Legal is not the same as FDA-reviewed: compounded products have not gone through the agency's premarket review for safety, quality or effectiveness and the FDA has published warnings about dosing errors and adverse events tied to them.
What did the FDA say about compounded semaglutide?
The agency has warned that compounded drugs pose higher risk than FDA-approved drugs because they lack premarket review and it has received reports of dosing errors and serious adverse events with compounded injectable semaglutide, some requiring hospitalization. The FDA has also stated it is not aware of a basis for compounding semaglutide using salt forms.
Why do compounded programs charge more for higher doses?
Because the product is priced by the compounding pharmacy per unit of active ingredient, so more drug costs more money. That structure creates a financial incentive to escalate dose, which is the opposite of the clinical goal of finding the lowest effective dose. Branded products are priced by the manufacturer, not by your dose.
Does GoodLife Health ever prescribe compounded GLP-1s?
No, never. Our clinicians prescribe branded, FDA-approved medication only: Wegovy, Zepbound, Ozempic, Mounjaro, Wegovy Tablets and Foundayo. When branded is not clinically appropriate, we do not substitute a compounded copy to keep a subscription alive.
What does the medication cost through GoodLife Health?
The pharmacy you choose bills you at its own price, at pharmacy cost, with zero markup, no molecule upcharge and no dose upcharge from us. The $299 monthly fee covers the doctor and the quarterly Biomarker Audit and never changes with your prescription.
Is this available outside the United States?
No. Our clinicians are licensed to practice in the fifty states and the membership serves United States residents only.
One last thing
If the five checks just described your current vial, the next question is not whether it is working today. It is who is accountable when it stops working or starts causing trouble. If you want branded product and a clinician who can answer for the dose, the eligibility check is free, takes a few minutes and never results in a charge unless a clinician accepts you into care.
Related Guides
- Why we will never prescribe compounded GLP-1s
- Compounded vs branded GLP-1: why not cheaper
- The real 12-month cost of compounded GLP-1s
- What will my GLP-1 medication actually cost